{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361981470102385664.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1038/nrd4597"}},{"identifier":{"@type":"URI","@value":"http://www.nature.com/articles/nrd4597.pdf"}},{"identifier":{"@type":"URI","@value":"http://www.nature.com/articles/nrd4597"}}],"dc:title":[{"@value":"The pharmacology of second-generation chimeric antigen receptors"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381981470102385666","@type":"Researcher","foaf:name":[{"@value":"Sjoukje J. C. van der Stegen"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470102385665","@type":"Researcher","foaf:name":[{"@value":"Mohamad Hamieh"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470102385664","@type":"Researcher","foaf:name":[{"@value":"Michel Sadelain"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"14741776"},{"@type":"EISSN","@value":"14741784"}],"prism:publicationName":[{"@value":"Nature Reviews Drug Discovery"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2015-07","prism:volume":"14","prism:number":"7","prism:startingPage":"499","prism:endingPage":"509"},"reviewed":"false","dc:rights":["http://www.springer.com/tdm"],"url":[{"@id":"http://www.nature.com/articles/nrd4597.pdf"},{"@id":"http://www.nature.com/articles/nrd4597"}],"createdAt":"2015-07-01","modifiedAt":"2024-06-09","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360017978256640896","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"DMPK perspective on quantitative model analysis for chimeric antigen receptor cell therapy: Advances and challenges"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617903933696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A single-chain antibody generation system yielding CAR-T cells with superior antitumor function"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298757453115520","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Enrichment of T-cell proliferation and memory gene signatures of CD79A/CD40 costimulatory domain potentiates CD19CAR-T cell functions"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588381048669184","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Co-stimulation of CD28/CD40 signaling molecule potentiates CAR-T cell efficacy and stemness"}]},{"@id":"https://cir.nii.ac.jp/crid/1390307746610583552","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Beyond malignancies: Clinical advancements of CAR T-cell in the treatment of autoimmune diseases"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1038/nrd4597"},{"@type":"CROSSREF","@value":"10.1016/j.dmpk.2024.101003_references_DOI_4pGcOb2rVdFQUWz7oGgrpsC0HKW"},{"@type":"CROSSREF","@value":"10.1038/s42003-021-01791-1_references_DOI_4pGcOb2rVdFQUWz7oGgrpsC0HKW"},{"@type":"CROSSREF","@value":"10.3389/fimmu.2022.1064339_references_DOI_4pGcOb2rVdFQUWz7oGgrpsC0HKW"},{"@type":"CROSSREF","@value":"10.1016/j.omton.2024.200837_references_DOI_4pGcOb2rVdFQUWz7oGgrpsC0HKW"},{"@type":"CROSSREF","@value":"10.5582/irdr.2025.01057_references_DOI_4pGcOb2rVdFQUWz7oGgrpsC0HKW"}]}